BioMed Research International / 2020 / Article / Tab 5

Research Article

The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer

Table 5

Univariate and multivariate Cox logistic regression analysis of overall survival in patients with prostate cancer.

Clinicopathological featuresUnivariateMultivariate
HR95% CI valueHR95% CI value

Age1.3080.563-3.0390.533
Preoperative PSA level1.3280.783-2.2530.293
Gleason score2.3131.299-4.1180.0041.3470.630-2.8780.442
pT stage1.5380.672-3.5200.308
Metastasis status3.3631.390-8.1340.0071.5720.564-4.3870.387
Hormone therapy0.3060.072-1.3080.110
PSCA expression level10.0681.355-74.8050.0244.2500.466-38.7340.199
NSE expression level3.8411.647-8.9570.0021.7110.638-4.5840.286
Surgical intervention2.3461.014-5.4280.0461.7500.730-4.1920.210

Abbreviations: HR: hazard ratio; CI: confidence interval; pT stage: pathologic tumor stage; PSCA: prostate stem cell antigen; NSE: enolase 2.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.